TCW Group Inc. bought a new position in shares of Grail, Inc. (NASDAQ:GRAL – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 285,435 shares of the company’s stock, valued at approximately $5,095,000.
Several other large investors have also recently added to or reduced their stakes in the company. abrdn plc acquired a new stake in shares of Grail during the 4th quarter worth approximately $3,768,000. Douglas Lane & Associates LLC bought a new position in Grail in the fourth quarter worth $3,034,000. Slow Capital Inc. acquired a new stake in Grail during the fourth quarter worth $2,379,000. 180 Wealth Advisors LLC bought a new stake in Grail in the 4th quarter valued at $1,681,000. Finally, Moloney Securities Asset Management LLC acquired a new position in shares of Grail in the 4th quarter valued at $559,000.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on GRAL. Morgan Stanley began coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock. Wolfe Research began coverage on shares of Grail in a research note on Friday, November 15th. They set a “peer perform” rating for the company.
Grail Trading Down 14.7 %
Shares of NASDAQ:GRAL opened at $40.73 on Monday. The business’s fifty day moving average price is $26.69 and its two-hundred day moving average price is $19.24. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.
Grail (NASDAQ:GRAL – Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. Sell-side analysts predict that Grail, Inc. will post -15.15 EPS for the current year.
About Grail
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Featured Stories
- Five stocks we like better than Grail
- What is MarketRankā¢? How to Use it
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Quiet Period Expirations Explained
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is Insider Trading? What You Can Learn from Insider Trading
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Grail, Inc. (NASDAQ:GRAL – Free Report).
Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.